Preliminary scientific tests point out conolidine may perhaps inhibit specific ion channels, decreasing neuronal excitability and limiting agony alerts. This mechanism is especially suitable in neuropathic agony, where by abnormal signaling triggers persistent pain. Additionally, conolidine seems to affect G protein-coupled receptor (GPCR) pathways